Novo Nordisk
NVO
#25
Rank
HK$3.035 T
Marketcap
HK$684.32
Share price
5.18%
Change (1 day)
-27.95%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of December 2024 : HK$504.95 Billion

According to Novo Nordisk's latest financial reports the company's total assets are HK$504.95 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$363.76 B34.01%
2022-12-31HK$271.45 B17.56%
2021-12-31HK$230.91 B24.34%
2020-12-31HK$185.70 B26.61%
2019-12-31HK$146.67 B10.37%
2018-12-31HK$132.89 B3.09%
2017-12-31HK$128.92 B20.38%
2016-12-31HK$107.09 B2.71%
2015-12-31HK$104.26 B6.8%
2014-12-31HK$97.62 B-3.32%
2013-12-31HK$100.98 B11.88%
2012-12-31HK$90.25 B3.1%
2011-12-31HK$87.54 B2.65%
2010-12-31HK$85.27 B4.3%
2009-12-31HK$81.76 B11.08%
2008-12-31HK$73.60 B0.93%
2007-12-31HK$72.93 B18.32%
2006-12-31HK$61.63 B19.84%
2005-12-31HK$51.43 B-3.55%
2004-12-31HK$53.32 B17.95%
2003-12-31HK$45.21 B31.32%
2002-12-31HK$34.42 B9.11%
2001-12-31HK$31.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$1.705 T 237.69%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$587.41 B 16.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$719.46 B 42.48%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.080 T 114.01%๐Ÿ‡ซ๐Ÿ‡ท France